News
Dismay as FDA blocks Regenxbio's Hunter syndrome therapy
The FDA said it needs more information before it can approve Regenxbio's gene therapy for Hunter syndrome, in a devastating decision for patients.
News
Novo Nordisk rises as Hims & Hers backs down on oral GLP-1
Novo Nordisk's battered stock enjoyed a reprieve after Hims & Hers abandoned plans to launch a compounded version of the new Wegovy pill.
News
Hims & Hers copies Novo Nordisk's new Wegovy pill
Competition has already arrived for Novo Nordisk's Wegovy pill, as telehealth company Hims & Hers launches a compounded version.
News
Amgen baulks at FDA request to withdraw Tavneos
Amgen confirmed on its fourth-quarter results call that it has resisted a request to pull Tavneos for ANCA-associated vasculitis from the US market.
News
Abbott's wireless heart failure sensor cleared for NHS use
A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
